A common variant of a gene called CACNA1G — which makes a channel that helps regulate calcium flow between cells — may increase the risk of developing autism, according to research published in Molecular Psychiatry.

The molecular defects that cause some cases of autism may arise during the development of neuronal stem cells, according to a new theory bolstered by several independent animal and human studies.

Applying an emerging technique that combines genetic data and brain scans, researchers have identified two new genes involved in schizophrenia. The method, called ‘imaging genetics’, holds promise for linking genes to brain function in complex psychiatric disorders, including autism.

The answer to a long-standing mystery in visual neuroscience may also help explain how people with autism perceive faces, according to a study published in March in the Proceedings of the National Academy of Sciences.

The characteristic inability of a person with autism to respond to emotions may stem from sustained arousal in the amygdala, the brain region needed to interpret emotions from facial expressions.

In the spring of 2002, as a new graduate student at the University of Washington, Raphael Bernier was charged with introducing his advisor, Geraldine Dawson, before her lecture to a room of about 40 people from the psychology department. To Dawson’s astonishment, Bernier sang his introduction to the tune of On Top of Old Smokey. “[It was] a pretty gutsy thing for a first-year student to do,” Dawson says.

In the late 1990s, after Daniel Geschwind had established himself as an expert on the genetics of neurological diseases, a personal connection abruptly pulled him into autism research. Since then, he has participated in dozens of studies probing the genetic basis of autism and related neuro-developmental disorders.

Rebecca Saxe has been designing brain imaging experiments to study infant brain development, moral judgment and theory of mind in people with autism, who often have trouble grasping othersʼ thoughts.

In 2003, Stephane Jamain and his colleagues reached a breakthrough by taking a candidate approach to the X chromosome, and linking members of the neuroligin protein family to autism.

A new slow-release form of the drug risperidone ― an antipsychotic given to people with schizophrenia, autism and other psychiatric conditions ― lasts in the blood days instead of hours, according to research presented today at the Society for Neuroscience meeting.